Baby born with heart defect treated with cord blood stem cells

Baby Ryals was diagnosed with a rare genetic heart condition whilst he was still in the womb. Hypoplastic left heart syndrome is a rare and complex form of congenital heart disease in which the left side of a child’s heart is severely underdeveloped. The prognosis for Ryals at birth was deeply worrying, and the baby’s father talks on the film below about preparing for his newborn son’s funeral, but a new therapy gave the family hope.

The Mayo Clinic in Philidelphia used umbilical cord blood stem cells from Ryall’s own body to stimulate growth in the right ventricle of his heart. Ryals was the fifth baby to undergo this therapy at Mayo and the Clinic has now developed a consortium to assist more children with congenital heart defects. Ryals is now a smiley happy baby with a bright future.


stem cell preservation

BSc (Hons) Microbiology

Chief Executive Officer | Biovault Family

Biovault Family CEO, Kate Sneddon, joined Biovault in July 2009 and became Chief Executive Officer in 2016. As health industry professional her experience includes working as a microbiologist and leader at GSK for over 10 years. Her expertise in cord blood banking has been recognised in her awards, features in Parliamentary Review and Parents Guide to Cord Blood, as well as contributions to research with UCL and others.

Request a Brochure

Find out more.

Our hope is that the information in this brochure will empower you as you weigh-up your cord blood and tissue storage options and prepare for your family’s healthy future.

Download your free guide to Biovault Family's cord blood banking!